|
Activities, Bill Numbers and Titles
|
|
|
|
Client: Pharmaceutical Research and Manufacturers of America, Inc.
|
|
|
|
Senate Bill
|
2409
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$800.94
|
N/A
|
|
Senate Bill
|
2796
|
An Act Putting Patients First
|
Neutral
|
$39.07
|
N/A
|
|
House Bill
|
4134
|
An Act to improve health care by investing in VALUE
|
Oppose
|
$800.93
|
N/A
|
|
Senate Bill
|
2769
|
An Act Putting Patients First
|
Neutral
|
$39.07
|
N/A
|
|
Executive
|
Massachusetts Health Policy Commission (HPC)
|
Discussed issues related to 958 CMR 12.00: Drug pricing review
|
Oppose
|
$664.19
|
N/A
|
| | | |
Total amount
|
$2,344.20
| |
|
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|